
| Line item | FY2025 |
|---|---|
| Valuation | |
| Market cap | $235 |
| Enterprise value | $234 |
| P/E (TTM) at period end | – |
| P/S (TTM) at period end | – |
| P/B at period end | – |
| EV / EBITDA (TTM) | – |
| EV / Sales (TTM) | – |
| Returns | |
| Return on equity | – |
| Return on invested capital | – |
| Dividend yield | – |
| Financial health | |
| Current ratio | 1.00× |
| Debt / equity | – |
| Effective tax rate | – |
| Share count | |
| Diluted shares outstanding | – |
| Line item | TTM | FY2025 |
|---|---|---|
| Revenue and gross profit | ||
| Revenue | – | – |
| Cost of revenue | – | – |
| Gross profit | – | – |
| Operating expenses | ||
| Research and development | – | – |
| Selling, general and administrative | – | – |
| Total operating expenses | – | – |
| Total costs and expenses | ($1) | – |
| Operating income | ($1) | – |
| Earnings | ||
| EBITDA | – | – |
| Interest income | – | – |
| Interest expense | – | – |
| Pre-tax income | – | – |
| Income tax expense | – | – |
| Net income | $4 | – |
| Per share | ||
| Diluted EPS (GAAP) | – | – |
| Basic EPS (GAAP) | – | – |
| Basic shares outstanding | – | – |
| Margins | ||
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |